Corneal Refractive Surgery Considerations in Patients on Dupilumab

Dupilumab is a biologic approved by the United States Food and Drug Administration (US FDA) for the treatment of atopic dermatitis. While it is an effective medication for eczema, ocular side effects are common in patients receiving dupilumab therapy. Greater consideration is needed when evaluating...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshirfar, Majid, Seitz, Tanner, Ply, Brianna, Ronquillo, Yasmyne C., Hoopes, Phillip C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225227/
https://www.ncbi.nlm.nih.gov/pubmed/35743344
http://dx.doi.org/10.3390/jcm11123273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225227/
https://www.ncbi.nlm.nih.gov/pubmed/35743344
http://dx.doi.org/10.3390/jcm11123273

Ejemplares similares